<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_EPF-Lausanne_Safety"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:EPF-Lausanne/Safety">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:EPF-Lausanne/Safety&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:EPF-Lausanne/Safety&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:EPF-Lausanne/Safety&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:EPF-Lausanne/Safety" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:EPF-Lausanne/Safety</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2012.igem.org</H3><DIV class="all"><DIV class="menu"><UL class="simple-navi"><LI class="menu-introduction"><A href="/Team:EPF-Lausanne"><SPAN>Introduction</SPAN></A></LI><LI class="menu-project"><A href="/Team:EPF-Lausanne/Project"><SPAN>Our Project</SPAN></A></LI><LI class="menu-notebook"><A href="/Team:EPF-Lausanne/Notebook"><SPAN>Notebook</SPAN></A></LI><LI class="menu-human"><A href="/Team:EPF-Lausanne/HumanPractices"><SPAN>Human Practices</SPAN></A></LI><LI class="menu-acknowledgments"><A href="/Team:EPF-Lausanne/Acknowledgments"><SPAN>Acknowledgments</SPAN></A></LI></UL></DIV><DIV class="paper"><DIV class="paper-inner row-fluid"><DIV class="page-content span8"><DIV>

These are our answers to the iGEM <AHREF><SPAN>mandatory safety questions</SPAN>, submitted on the 7th of September 2012.

<OL start="1"><LI><B><SPAN>Would any of your
     project ideas raise safety issues in terms of: </SPAN></B></LI><UL><LI><SPAN>researcher safety, </SPAN></LI><LI><SPAN>public safety, or </SPAN></LI><LI><SPAN>environmental safety?</SPAN></LI></UL></OL><P><SPAN>To answer this question, we
thought about how the different elements we use in our experiments could be
dangerous separately or together.</SPAN></P><P><SPAN>The bacteria we use for all
of our cloning steps are <I>E.Coli</I></SPAN><A href="http://ecoliwiki.net/colipedia/index.php/DH5_alpha"><SPAN>DH5α</SPAN></A><SPAN>
(originally developed by Prof. </SPAN><A href="http://people.epfl.ch/douglas.hanahan?lang=en"><SPAN>Douglas Hanahan</SPAN></A><SPAN>, currently
head of the Cancer Research Institute at EPFL). They derive from the </SPAN><A href="http://ecoliwiki.net/colipedia/index.php/Strain:E._coli_K-12"><SPAN>K-12</SPAN></A><I><SPAN>E.Coli</SPAN></I><SPAN> strain, which has been improved over the years to yield
a high number of non-mutated and non-degraded foreign plasmids, but also to
stop being virulent. They are no longer able to attach to the human gut and to
infect it or form biofilms because they have lost the fimbriae that allowed
them to do so. They are classed as safety level 1 according to the WHO.</SPAN></P><P><SPAN>The mammalian cells we use
are </SPAN><A href="http://www.invitrogen.com/site/us/en/home/Products-and-Services/Applications/Cell-Culture/Mammalian-Cell-Culture/mammalian-misc1/cho_cells.html"><SPAN>CHO (Chinese Hamster Ovary) DG44</SPAN></A><SPAN> cells. Even though this is an “immortalized” cell
line, it is established and proven not to be dangerous. Even if the researcher
had a cut on his skin which came in contact with the CHO cells, an enormous
amount of these would be required for any inoculation potential.</SPAN></P><P><SPAN>The genes we use work as
light-sensitive switches (LovTAP-VP16 and melanopsin) that initiate the
transcription of a readout protein. LovTAP is an artificial construct (its <I>Lov</I>
domainhas been originally isolated from <I>Avenasativa</I>, the common oat).
The melanopsin switch we received from Prof. </SPAN><A href="http://www.bsse.ethz.ch/people/martinf"><SPAN>Martin
Fussenegger</SPAN></A><SPAN> (ETHZ) is human. The
other constructs we work with are readouts (quantifiable common proteins such
as dsRed, GFP, SEAP, TNFR…) and the NFAT response element. None of these are
hormones, oncogenes, or cytokines. They also have no known toxicity.</SPAN></P><P><SPAN>Every team member has taken
the </SPAN><A href="http://sv-safety.epfl.ch/page-31011-en.html"><SPAN>Laboratory Safety Course</SPAN></A><SPAN> of EPFL, taught by Dr. </SPAN><A href="http://people.epfl.ch/stephane.karlen?lang=en"><SPAN>Stéphane Karlen</SPAN></A><SPAN>, and is
aware of the potential dangers of laboratory work.</SPAN></P><P><SPAN>All of the above
considerations lead us to the conclusion that researcher risks are minimal.
They never exceed safety level 1.</SPAN></P><P><SPAN>Public safety risks are
non-existent, as the genetically modified cells we use would be unable to
survive outside of their favourite conditions in a laboratory environment, and
as none of the organisms or parts in our experiments are virulent or contagious.</SPAN></P><P><SPAN>Environmental risks are being
taken care of by inactivating and eliminating all of the genetically modified
biowaste in accordance with the EPFL guidelines. Such risks are thus also
non-existent.</SPAN></P><OL start="2"><LI><B><SPAN>Do any of the new
     BioBrick parts (or devices) that you made this year raise any safety
     issues? If yes, </SPAN></B></LI><UL><LI><SPAN>did you document these
      issues in the Registry? </SPAN></LI><LI><SPAN>how did you manage to
      handle the safety issue? </SPAN></LI><LI><SPAN>How could other teams
      learn from your experience?</SPAN></LI></UL></OL><P><SPAN>Please refer to question one
for more details on the genetic constructs we use. The BioBrick we have the
most interest in is LovTAP-VP16. It is a modified version of </SPAN><A href="https://2009.igem.org/Team:EPF-Lausanne/LOVTAP"><SPAN>the protein</SPAN></A><SPAN> that has been
submitted as a BioBrick in 2009 by the EPFL team. It is now fused to a VP16
domain to allow mammalian expression. Neither the existing protein, neither the
changes it has undergone can lead to any known risks. This is a simple system
and the DNA binding is controlled by light.</SPAN></P><P><SPAN>The other BioBricks we submit
this year do not raise any safety issues either.</SPAN></P><OL start="3"><LI><B><SPAN>Is there a local
     biosafety group, committee, or review board at your institution? </SPAN></B></LI><UL><LI><SPAN>If yes, what does your
      local biosafety group think about your project? </SPAN></LI><LI><SPAN>If no, which specific
      biosafety rules or guidelines do you have to consider in your country? </SPAN></LI></UL></OL><P><SPAN>There is one. We have had a
meeting with Dr. </SPAN><A href="http://people.epfl.ch/stephane.karlen?lang=en"><SPAN>Stéphane Karlen</SPAN></A><SPAN>, who is the Biosafety Coordinator at EPFL. He has kindly agreed to
conduct an assessment of our project.</SPAN></P><P><SPAN>According to his analysis, no
elements of risk group 2 or higher have been identified. The project always
remains at a security level one.</SPAN></P><P><SPAN>The laboratory we mostly work
in (</SPAN><A href="http://lbtc.epfl.ch/"><SPAN>LBTC</SPAN></A><SPAN>, Prof. </SPAN><A href="http://people.epfl.ch/florian.wurm?lang=en"><SPAN>Florian
Wurm</SPAN></A><SPAN>’s group) adheres to the EPFL </SPAN><A href="http://sv-safety.epfl.ch/page-30998.html"><SPAN>biosafety</SPAN></A><SPAN> requirements, including the management of genetically
modified waste (chemical and autoclave). The laboratories are correctly
equipped.</SPAN></P><P><SPAN>Given the above, we can
affirm that our project and our working environment respect <B>all of the Swiss
biosafety and biosecurity laws and guidelines</B>.</SPAN></P><OL start="4"><LI><B><SPAN>Do you have any other
     ideas how to deal with safety issues that could be useful for future iGEM
     competitions? How could parts, devices and systems be made even safer
     through biosafety engineering? </SPAN></B></LI></OL><P><SPAN>Every new iGEM team should be
informed about safety issues and guidelines. The basics of secure lab work
should be taught to them. The risks are minimized when everyone is aware of the
potential dangers of what they are doing, and is prepared to deal with them
accordingly.</SPAN></P><P><SPAN>In our case, depending on the
readout protein we use with the LovTAP-VP16 switch, leakage might need to be
minimized in order not to waste precious therapeutic proteins and to avoid
possible toxic effects on the producing cells. In order to prevent expression
without light, we might imagine another “safety switch” that would make sure no
protein is produced in the dark state through a feedback loop.</SPAN></P><P><SPAN>Such biological double checks
and controls might be useful in any iGEM project that might involve production
of a risky protein.</SPAN></P></AHREF></DIV><H2><SPAN class="mw-headline" id="Safety_class_06.06.2012"> Safety class 06.06.2012 </SPAN></H2></DIV></DIV></DIV><DIV class="footer"><DIV class="footer-inner"><DIV class="footer-inner-inner"><DIV class="row-fluid"><DIV class="span4"><H4>Wiki Links</H4><UL><LI><A href="https://2012.igem.org/Special:RecentChanges">Recent Changes</A></LI><LI><A href="https://2012.igem.org/Special:Upload?wpDestFile=Team-EPF-Lausanne_">Upload file</A></LI><LI><A href="https://2012.igem.org/Special:SpecialPages">Special Pages</A></LI><LI><A href="https://2012.igem.org/Special:Preferences">My Preferences</A></LI><LI><A href="https://2012.igem.org/2012.igem.org:Privacy_policy">Privacy Policy</A></LI><LI><A href="https://2012.igem.org/2012.igem.org:General_disclaimer">Disclaimers</A></LI></UL></DIV><DIV class="span4"><H4>Important pages</H4><UL><LI><A href="https://2012.igem.org/Team:EPF-Lausanne/Wiki">Wiki editing</A></LI><LI><A href="https://2012.igem.org/Team:EPF-Lausanne/Planning">Planning</A></LI><LI><A href="https://2012.igem.org/Team:EPF-Lausanne/Meetings">Meetings</A></LI><LI><A href="https://2012.igem.org/Team:EPF-Lausanne/PrimerDesignHelper">Primer Design Helper</A></LI><LI><A href="https://2012.igem.org/Team:EPF-Lausanne/AddPage">Add Page</A></LI><LI><A href="https://2012.igem.org/Team:EPF-Lausanne/Protocol">Protocol List</A></LI></UL></DIV><DIV class="span4"><H4>Pages</H4><UL><LI><A href="/Team:EPF-Lausanne">Home</A></LI><LI><A href="/Team:EPF-Lausanne/Team">Team</A></LI><LI><A href="https://igem.org/Team.cgi?year=2012&amp;team_name=EPF-Lausanne">Official Team Profile</A></LI><LI><A href="/Team:EPF-Lausanne/Project">Project</A></LI><LI><A href="/Team:EPF-Lausanne/Parts">Parts Submitted to the Registry</A></LI><LI><A href="/Team:EPF-Lausanne/Modeling">Modeling</A></LI><LI><A href="/Team:EPF-Lausanne/Notebook">Notebook</A></LI><LI><A href="/Team:EPF-Lausanne/Safety">Safety</A></LI><LI><A href="/Team:EPF-Lausanne/Attributions">Attributions</A></LI><LI><A href="/Team:EPF-Lausanne/Sponsors">Sponsors</A></LI><LI><A href="https://2012.igem.org/Team:EPF-Lausanne/ConceptArt">Concept Art</A></LI></UL></DIV></DIV></DIV></DIV></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2012.igem.org/Team:EPF-Lausanne/Safety">http://2012.igem.org/Team:EPF-Lausanne/Safety</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:EPF-Lausanne/Safety" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:EPF-Lausanne/Safety" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:EPF-Lausanne/Safety&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:EPF-Lausanne/Safety&amp;oldid=167393" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2012.igem.org:Privacy_policy" title="2012.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2012.igem.org:General_disclaimer" title="2012.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>